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Within the two neurogenic niches of the adult mamma-
lian brain, i.e., the subventricular zone lining the lateral
ventricle and the subgranular zone of the hippocampus,
there exist distinct populations of proliferating neural
precursor cells that differentiate to generate new neu-
rons. Numerous studies have suggested that epigenetic
regulation by histone-modifying proteins is important in
guiding precursor differentiation during development;
however, the role of these proteins in regulating neural
precursor activity in the adult neurogenic niches remains
poorly understood. Here we examine the role of an
NAD1-dependent histone deacetylase, SIRT1, in modu-
lating the neurogenic potential of neural precursors in the
neurogenic niches of the adult mouse brain. We show
that SIRT1 is expressed by proliferating adult subventric-
ular zone and hippocampal neural precursors, although
its transcript and protein levels are dramatically reduced
during neural precursor differentiation. Utilizing a lentivi-
ral-mediated delivery strategy, we demonstrate that
abrogation of SIRT1 signaling by RNAi does not affect
neural precursor numbers or their proliferation. However,
SIRT1 knock down results in a significant increase in
neuronal production in both the subventricular zone and
the hippocampus. In contrast, enhancing SIRT1 signal-
ing either through lentiviral-mediated SIRT1 overexpres-
sion or through use of the SIRT1 chemical activator
Resveratrol prevents adult neural precursors from differ-
entiating into neurons. Importantly, knock down of SIRT1
in hippocampal precursors in vivo, either through RNAi
or through genetic ablation, promotes their neurogenic
potential. These findings highlight SIRT1 signaling as a
negative regulator of neuronal differentiation of adult
subventricular zone and hippocampal neural pre-
cursors. VC 2013 Wiley Periodicals, Inc.
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Adult neurogenesis is a multistage process regulated
by a delicate balance between undifferentiated prolifera-
tive neural precursor cells and differentiated neuronal
progeny. There are two evolutionarily conserved neuro-
genic niches in the adult mammalian brain, the subven-
tricular zone (SVZ) that lines the lateral wall of the lateral
ventricle and the subgranular zone (SGZ) that lies within
the dentate gyrus of the hippocampus. Numerous regula-
tory transcription factors involved in stem cell self-
renewal and fate regulation have been identified for both
of these neurogenic niches (Ballas and Mandel, 2005;
Agathocleous et al., 2009; Briscoe, 2009; Wexler et al.,
2009). The progression of a neural stem cell to its differ-
entiated progeny requires the silencing of self-renewal
genes and the concurrent transcriptional activation of cell-
type specific genes. In recent years, the importance of epi-
genetic mechanisms in orchestrating precise changes in
gene expression profile has also become apparent. Epige-
netic modifications such as histone acetylation and deace-
tylation provide a crucial intrinsic mechanism by which
the differentiation of stem cells can be regulated (Hsieh
and Gage, 2004; Wen et al., 2009; Hirabayashi and
Gotoh, 2010; Hsieh and Eisch, 2010), with recent work
revealing histone deacetylases (HDACs) to be important
for lineage specification in neural stem cells both during
development and in the adult brain (Hsieh et al., 2004;
Balasubramaniyan et al., 2006; Lyssiotis et al., 2007; Sieb-
zehnrubl et al., 2007; Kohyama et al., 2008; Schneider
et al., 2008; Yu et al., 2009; Juliandi et al., 2010).
One such HDAC that has been shown to interact
with a large number of transcription factors and signaling
pathways involved in adult neurogenesis is SIRT1, a
class III NAD-dependent histone and protein deacetylase
that characteristically inhibits activity of its downstream
targets through transcriptional repression (Haigis and
Guarente, 2006). During development, SIRT1 is
robustly expressed throughout the central nervous sys-
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tem, suggesting a role for this sirtuin protein in neuronal
development (Sakamoto et al., 2004). In line with this,
Prozorovski and colleagues (2008) showed that SIRT1
influences cell fate decisions in embryonic neural precur-
sor cells. Recently, SIRT1 has been shown to regulate
pluripotency and differentiation genes in human embry-
onic stem cells (Calvanese et al., 2010). It has also been
found to be important in maintaining an undifferenti-
ated/self-renewing state in mouse embryonic stem cells
in vitro (Han et al., 2008). However, despite these lines
of evidence for a role of SIRT1 signaling in modulating
differentiation of various embryonic pluripotent cell
types, its role in adult neurogenesis has not yet been
investigated. The present study analyzes the effects of
SIRT1 knock down and overexpression on adult neural
precursor cells in the SVZ and SGZ. Our results reveal
that abrogation of SIRT1 signaling in proliferating neu-
ral precursors enhances neuronal differentiation, whereas
enhancing SIRT1 activity prevents adult neural precur-
sor cells from generating new neurons. These findings
highlight a novel role for SIRT1 signaling in regulating
the neurogenic potential of adult precursors in both the
SVZ and the SGZ.
MATERIALS AND METHODS
Animals
Adult (6–8 weeks of age, except where specifically
stated otherwise) male C57Bl/6 mice were used for this study.
The animals were housed in filter-top cages with unlimited
access to food and water, in a temperature- and humidity-
controlled room, and maintained on a 12-hr light/12-hr dark
cycle. The Sirt1CO/CO floxed mouse strain, in which the cata-
lytic domain exon 4 of the Sirt1 gene is flanked with the loxP
sequence, was generated by Li and colleagues (2007) and
obtained from The Jackson Laboratory. Mice homozygous for
the targeted alleles were maintained on a mixed 129X1/SvJ;
C57Bl/6 genetic background. These mice are viable and fer-
tile and express normal levels of Sirt1 protein (Li et al., 2007).
To convert the Sirt1 conditional CO allele into the Sirt1
knockout KO allele, Sirt1CO/CO mice were crossed with nes-
tin-Cre transgenic mice (kindly provided by Prof. Linda
Richards, Queensland Brain Institute, The University of
Queensland), in which the nestin promoter drives Cre expres-
sion (Tronche et al., 1999). Animals were treated in accord-
ance with the Australian Code of Practice for the Care and
Use of Animals for Scientific Purposes. Ethics approval for all
experiments was obtained from the University of Queensland
Animal Ethics Committee (QBI/224/10/NHMRC).
Genotyping
A PCR-based genotyping method was used to identify
the Sirt1 conditional targeted allele (CO) with the following
primers (Jackson Laboratory): Sirt1CO: forward 50-GGT TGA
CTT AGG TCT TGT CTG and reverse 50-CGT CCC
TTG TAA TGT TTC CC. The expected band sizes in base
pairs (bp) were mutant (CO/CO) 5 750 bp, heterozygote
(CO/1) 5 750 bp and 550 bp, wild-type (1/1) 5 550 bp.
To genotype for Sirt1 knockout (post Cre excision), we used
the following primers (Jackson Laboratory): Sirt1KO: forward
50-AGG CGG ATT TCT GAG TTC GA and reverse 50-
CGT CCC TTG TAA TGT TTC CC. Expected band sizes
were null (KO/KO) 5 450 bp, wild-type (1/1) 5 900 bp.
The presence or absence of the nestin-Cre transgene was
determined with the following primers (Jennemann et al.,
2005): nestin: forward 50-CCG CTT CCG CTG GGT CAC
TGT and reverse 50-GAC CGG CAA ACG GAC AGA
AGC A. A 380-bp band indicated the presence of Cre.
Primary Neurosphere Cultures
Adult male mice were killed by cervical dislocation;
their brains were immediately removed, and the hippocampus
or SVZ was dissected in HEPES-buffered minimum essential
medium (HEM) consisting of minimum essential medium
(Invitrogen, Carlsbad, CA) supplemented with 16 mM
HEPES (Sigma-Aldrich, St. Louis, MO) and 100 U/ml peni-
cillin/streptomycin (Invitrogen). SVZ tissue was mechanically
chopped using a scalpel blade and then enzymatically digested
with 0.1% trypsin-EDTA (Invitrogen) for 7 min at 378C, fol-
lowed by a wash with 0.014% w/v trypsin inhibitor (type I-S
from soybean; Sigma-Aldrich) dissolved in HEM. The tissue
was then centrifuged at 100 rcf for 7 min, after which the pel-
let was resuspended in 1 ml neurosphere growth medium.
Hippocampal tissue was also chopped finely using a scalpel
blade and then digested with 1 ml papain (Worthington Bio-
chemical, Lakewood, NJ) for 20 min at 378C with intermedi-
ate agitation provided by gently pipetting four or five times
every 6 min. The tissue was then centrifuged at 100 rcf for 7
min, after which the pellet was resuspended in 1 ml Hank’s
balanced salt solution (HBSS; Sigma-Aldrich). Next, the tissue
was centrifuged at 100 rcf for 7 min and resuspended in 1 ml
neurosphere growth medium. Both SVZ and hippocampal tis-
sue were then mechanically triturated before being filtered
through a 40-lm cell sieve (Falcon, BD Biosciences, San Jose,
CA). The neurosphere growth medium consisted of mouse
NeuroCult NSC Basal Medium plus mouse NeuroCult NSC
Proliferation Supplements (Stem Cell Technologies, Vancou-
ver, British Columbia, Canada) containing 2% bovine serum
albumin (Invitrogen) and 2 lg/ml heparin (Sigma-Aldrich).
Epidermal growth factor (EGF; 20 ng/ml purified mouse re-
ceptor grade; BD Biosciences), bovine fibroblast growth factor
(FGF-2; 10 ng/ml recombinant; Roche, Indianapolis, IN),
and 10 U/ml penicillin-G/10 mg/ml streptomycin (Invi-
trogen) were also included. The cells were plated at a density
of approximately one hippocampus or SVZ per 96-well plate
(Falcon, BD Biosciences) with 200 ll neurosphere medium
per well. Primary hippocampal cells and SVZ cells were incu-
bated for 14 and 7 days, respectively, at 378C in humidified
5% CO2 to permit neurosphere formation. At the end of this
period, the number of neurospheres was counted, and the
results were calculated as neurospheres per brain or per total
number of cells.
Resveratrol (3,4,5-trihydroxy-trans-stilbene; Sigma-
Aldrich) was used as a potential activator of Sirt1. Resveratrol
was dissolved in dimethylsulfoxide (DMSO; Sigma) to form a
10 mM stock solution, which was protected from light at all
times. For in vitro Resveratrol treatment of SVZ and/or hip-
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pocampal neural precursors, the stock solution was dissolved
in complete neurosphere growth medium at the time of plat-
ing, resulting in the final desired concentration of the drug
and a DMSO concentration of 0.2%. For control medium,
DMSO was added to complete medium at a final concentra-
tion of 0.2%.
Differentiation of Neurospheres
To provide an adherent surface on which the neuro-
spheres could differentiate, 18-mm round glass coverslips were
sterilized and precoated with 15 lg/ml poly-L-ornithine
(Sigma) and laminin (natural mouse; Invitrogen). Cultured
neurospheres (7 days for SVZ neurospheres and 14 days for
hippocampal neurospheres) were collected and resuspended in
differentiation medium, free from growth factors, which con-
sisted of mouse NeuroCult NSC Basal Medium plus mouse
NeuroCult NSC Proliferation Supplements and 10 U/ml pen-
icillin-G/10 mg/ml streptomycin. Induction of neural differ-
entiation was initiated by plating the neurospheres on pre-
coated coverslips in 24-well plates. The neurospheres were
then allowed to differentiate for 5–6 days at 378C in a
humidified 5% CO2 incubator.
Immunocytochemistry
To assess differentiation potential, the differentiated neu-
rospheres were immersion fixed in 4% paraformaldehyde
(PFA) in 0.1 M phosphate-buffered saline (PBS) for 20 min at
room temperature. After three rinses in 0.1 M PBS, they
were placed in blocking solution, comprising 0.1 M PBS con-
taining 0.1% Triton X-100 (0.1% PTX) and 2% normal goat
serum, for 1 hr and then were incubated at 48C overnight
with the neuronal marker bIII-tubulin (1:2,000; Promega,
Madison, WI) diluted in 0.1% PTX. The neurospheres were
then rinsed with 0.1% PTX and incubated for 2 hr at room
temperature with Alexa Fluor-conjugated secondary antibodies
diluted in 0.1% PTX (1:2,000; Molecular Probes, Eugene,
OR). The coverslips were then rinsed with 0.1% PTX, coun-
terstained with the nuclear marker 4,6-diamidino-2-phenylin-
dole (DAPI; 1:1,000), and mounted on glass slides using fluo-
romount (Dako Cytomation, Carpinteria, CA), before being
viewed on a Zeiss Axio-Imager microscope. Images were cap-
tured using a digital camera linked to a computer running
Zeiss Axiovision software. For quantification, similarly sized
neurospheres were used, and the percentage of neurospheres
expressing a given marker was estimated. At least 50 neuro-
spheres were counted for each condition.
Lentiviral Constructs
Single-hairloop RNAs (shRNAs) designed specifically
for Sirt1 were ordered as single-stranded oligonucleotides
(Geneworks, Hindmarsh, South Australia, Australia) and
annealed in a buffer containing 100 mM Tris HCl (pH 7.5), 1
M NaCl, and 10 mM EDTA. The Sirt1shRNA sequence
used for our experiments has previously been shown to knock
down SIRT1 effectively (Cohen et al., 2004). A random
sequence generated by scrambling the nucleotides in the Sirt1-
specific shRNA sequence, without homology to any known
mRNA, was used as a control. shRNAs were then inserted
into the transfer plasmid hCMV.GFP.U6.WPRE (kindly pro-
vided by Dr. Nigel McMillan, Diamantina Institute, The Uni-
versity of Queensland), under the U6 promoter. The corre-
sponding oligonucleotides used for generating the Sirt1
shRNA were Sirt1shRNA: forward 50-TGA AGT TGA
CCT CCT CAT TGT TTC AAG AGA ACA ATG AGG
AGG TCA ACT TCT TTT TTC and reverse 50-TCG AGA
AAA AAG AAG TTG ACC TCC TCA TTG TTC TCC
TGA AAC AAT GAG GAG GTC AAC TTC A,
ScramshRNA: forward 50-TGC GAT TAC GCT TTC GAA
TCT TTC AAG AGA AGA TTC GAA AGC GTA ATC
GCT TTT TTC and reverse 50-TCG AGA AAA AAG CGA
TTA CGC TTT CGA ATC TTC TCT TGA AAG ATT
CGA AAG CGT AAT CGC A.
For SIRT1 overexpression, we made use of the lentivi-
ral transfer plasmid flap-Ub promoter-IRES-GFP-WRE (Dr.
Nigel McMillan), containing the ubiquitin promoter, with an
IRES site and green fluorescent protein (GFP) to be able to
overexpress SIRT1 and fluorescently label the infected cells.
To generate the SIRT1 overexpression lentiviral transfer vec-
tor, Sirt1 cDNA was excised out of pUSEamp vector (Milli-
pore, Bedford, MA) with an EcoR1 restriction digest, blunted
at the ends using Klenow fragment, and ligated with BamH1-
digested and blunted flap-Ub promoter-IRES-GFP-WPRE
vector.
Lentiviral Production
We have used third-generation lentiviral vectors, which
are derived from human immunodeficiency virus (HIV; Dull
et al., 1998). These pMDLg/pRRE, pRSV-Rev and
pMD2.VSV-G lentiviral packaging plasmids were kindly pro-
vided by Dr. Nigel McMillan. Lentiviral stocks were pro-
duced by calcium phosphate transfection into HEK 293T
cells, as previously described (Follenzi et al., 2002; Tiscornia
et al., 2006). Briefly, supernatants were collected, passed
through a 0.45-lm filter, and then concentrated by ultracen-
trifugation. Expression titers were estimated on HEK 293T
cells by limiting dilution. The concentrated lentivector titer
ranged from 1 3 109 to 1 3 1010 transducing units (TU)/ml
for each vector. All viral stocks used for injections were
diluted to 1 3 109 TU/ml using PBS.
Transfection and Western Blot Analysis
Floating neurospheres were collected in a 10-ml Falcon
tube and spun down at 700 rpm for 5 min. The medium was
aspirated, and the cells were lysed by the addition of 100 ll of
a detergent-based cell lysis buffer. Differentiated neurospheres
were washed once with ice-cold PBS, lysed with 100 ll of
lysis buffer, and immediately scraped off the wells. Lysates
were transferred to 1.5-ml Eppendorf tubes and spun at
13,000 rcf for 10 min at 48C. The supernatant was collected
and the protein content in cell lysates was determined using
the BSA Protein Assay Kit (Bio-Rad, Hercules, CA).
For Western blotting, equal protein amounts of cell
lysates were subjected to SDS-PAGE and transferred to a pol-
yvinylidene fluoride membrane (Millipore). The membrane
was incubated in blocking solution (0.1 M PBS with 0.1%
Tween-20 and 5% nonfat milk powder) for 2 hr before being
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incubated overnight at 48C with primary antibodies against
SIRT1 (1:5,000; Millipore) and b-actin (1:5,000; Sigma),
diluted in blocking buffer. After washing five times for 5 min
in PBS containing 0.1% Tween 20, secondary horseradish per-
oxidase-conjugated donkey anti-rabbit (1:10,000; Santa Cruz
Biotechnology, Santa Cruz, CA) or donkey anti-mouse
(1:10,000; Santa Cruz Biotechnology) antibody was added,
and the membranes were incubated for 1.5 hr at room tem-
perature. After a final 5-min wash, membranes were exposed
to enhanced chemiluminescence detection solution (ECL-
Plus; Pierce, Rockford, IL) for 5 min to allow the membrane
to develop. For quantification, protein levels were normalized
to the levels of b-actin.
Reverse-Transcription Followed by Quantitative PCR
The expression of mouse transcripts was determined by
reverse transcription of total RNA followed by quantitative
PCR analysis (qRT-PCR). After a DNAse treatment, 2 lg
total RNA was reverse transcribed (SuperScript First-Strand
Synthesis System) according to the manufacturer’s protocol.
The quantitative real-time reverse transcriptase PCR (qRT-
PCR) reactions were performed on the Rotor-gene 6000
real-time PCR detection system (Corbett Lifesciences, Valen-
cia, CA) using the SYBR Green mix (Bio-Rad) with the fol-
lowing primers (supplied by Geneworks): Sirt1: forward 50-
GCA GAT TAG TAA GCG GCT TGA G and reverse
50-GGG CCT CTC CGT ATC ATC TT, b-actin: forward
50-CAC ACT GTG CCC ATC TAC GA and reverse 50-
GTG GTG GTG AAG CTG TAG CC.
PCR runs were performed using the following thermal
cycling conditions: 3 min at 958C followed by 40 cycles of 1
sec at 958C for denaturation, 15 sec at 608C for primer
annealing, and 5 sec at 728C for elongation. A melt curve
from 708C to 998C (0.58C/sec) was performed to analyze the
specificity of the primers and the quality of the product. Sam-
ple reactions were run in triplicate. For each set of triplicates,
the mean value for each gene transcript was determined, and
the obtained values were normalized against the housekeeping
gene b-actin to calculate the fold changes (treatment vs.
untreated control) in relative gene expression. A PCR control
on RNA that had not been reverse transcribed was included
at all times to make sure that no genomic DNA had been
amplified.
Lentiviral Infection
For in vitro infection of neural precursor cells, primary
dissociated cells were obtained as previously described and
then plated in 24-well plates at a density of 2 3 104 cells/ml/
well. The plates were kept in a humidified 5% CO2/378C tis-
sue culture incubator. At 6 hr postplating, 2 ll of the respec-
tive lentiviral stocks was added directly to each well (approxi-
mately 2 3 106 TU/well), after which the plates were
returned to the incubator. Infection efficiencies of at least 90%
were obtained as assessed by the number of GFP-positive neu-
rospheres formed.
To study the influence of knock down of SIRT1 signal-
ing on adult hippocampal progenitors in vivo, 10-week-old
male C57BL/6 mice were anesthetized with a mixture of ke-
tamine (100 mg/kg; Apex Laboratories, Farmingdale, NY)
and the muscle relaxant xylazine (5 mg/kg; Bayer). Mice
were fixed in a stereotactic apparatus (David Kopf Instru-
ments, Tujunga, CA) using ear and nose bars, and a small
midline incision was nade to expose the skull. A 20-ll glass
capillary was filled with lentiviral stock, attached to a manual
picoliter injector and set to the following coordinates relative
to Bregma (in mm): anterior–posterior 22, mediolateral
11.5, dorsoventral –2. The skull was drilled at these coordi-
nates to expose the brain, and the capillary was very slowly
(over 3–5 min) inserted into the brain to the required depth.
At a flow rate of approximately 0.1 ll/min, 0.5–1 ll viral sus-
pension was injected into the brain. After the injection was
finished, the capillary was left in place for up to 5 min. The
capillary was then slowly retracted, and the skull hole was
filled with bone wax, after which the skin was glued with tis-
sue glue and the mouse was placed on a heating pad to
recover and then returned to the home cage. The mice were
perfused with ice-cold 4% paraformaldehyde (PFA) 2 weeks
postsurgery.
BrdU Pulse Chase Assay
To analyze the neurogenic potential of neural precursors
in vivo, we performed a 5-bromo-20-deoxyuridine (BrdU)
pulse chase assay. Mice were given intraperitoneal pulses of
100 mg/kg BrdU every 12 hr for 2 days and then sacrificed 1
week after the last BrdU pulse. The number of BrdU-express-
ing cells provided an index of proliferation, and the percent-
age of BrdU-expressing cells that colabeled for neuronal
markers gave a measure of the neurogenic potential of the
dividing cells. Alternatively, to look at the survival of dividing
cells, the mice were given intraperitoneal injections of 100
mg/kg BrdU every 12 hr for 3 days and were sacrificed 2
weeks after the last BrdU dose. The number of BrdU-express-
ing cells present after 2 weeks provided an estimate of the sur-
vival rate of dividing cells.
Immunohistochemical Analysis
Adult animals were transcardially perfused with chilled
0.1 M PBS followed by 4% PFA. The brains were removed
and postfixed overnight in 4% PFA, followed by washes in
PBS. The brain tissue was cryoprotected by incubation in
30% w/v sucrose in 0.1 M PBS overnight, after which 40-lm
sections were cut using a freezing microtome. Every fourth
slice was used for immunohistochemical analysis. The sections
were permeabilized by washing three times with PBS contain-
ing 0.3% Triton X (0.3% PTX), blocked in 0.3% PTX con-
taining 3% normal goat serum for 1 hr, then labeled with the
following primary antibodies: mouse anti-SIRT1 (1:500;
Chemicon, Temecula, CA), rabbit anti-SIRT1 (1:1,000;
Millipore), the immature neuronal marker rabbit antidouble-
cortin (DCX; 1:500; Sapphire Bioscience, Waterloo, New
South Wales, Australia), the astroglial marker rabbit antiglial
fibrillar acidic protein (GFAP; 1:500; Dako Cytomation), and
the proliferative marker rabbit anti-Ki67 (1:500; Novacastra,
Buffalo Grove, IL). BrdU immunohistochemistry was per-
formed essentially as described previously (Kulkarni et al.,
2002). In brief, this involved DNA denaturation and acid hy-
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drolysis followed by overnight incubation with mouse anti-
BrdU antibody (1:500; Roche). After incubation with the re-
spective primary antibodies, the sections were washed three
times using 0.1% PTX and incubated for 2 hr at room tem-
perature with Alexa Fluor-conjugated secondary antibodies
(1:2,000; Molecular Probes) and DAPI (1:1,000). The sections
were mounted using Fluoromount (Dako Cytomation) and
viewed on a Zeiss Axio-Imager microscope. Optical section-
ing was achieved using ApoTome and images were captured
using a digital camera linked to a computer running Zeiss
Axiovision software. For quantification, the number of cells
expressing a given marker along the SGZ of the dentate gyrus
was counted.
Statistical Analysis
All results are presented as mean 6 SEM. Group com-
parisons were made with the Student’s t-test, and P < 0.05
was considered significant. In addition, for comparisons
among three or more groups, a one-way ANOVA was per-
formed to test for significance. In some cases, such as the
Resveratrol dose-response study, Dunnett’s posttest analysis
was performed to compare all groups with the control. In
experiments in which there were two variables, such as assess-
ing the effect of Resveratrol treatment on neuron distribution,
a two-way ANOVA with Bonferroni’s post hoc analysis was
used to determine the groups that were statistically significant.
All data were analyzed in the Prism statistical package.
RESULTS
SIRT1 Is Expressed in the Adult Neurogenic
Niches
To determine whether SIRT1 is expressed in the
neurogenic niches of the adult mouse brain, we stained
coronal sections containing the SVZ and hippocampus
with a SIRT1-specific antibody. Strong SIRT1 expres-
sion was observed in the SVZ, along the lateral wall of
the lateral ventricle (Fig.F1 1A). In the adult hippocampus,
SIRT1 was expressed throughout the dentate gyrus,
including the SGZ (Fig. 1B, inset). To determine
whether SIRT1 was expressed in the dividing cells
within this region, we colabeled SIRT1-positive cells
with the proliferation marker Ki67. All Ki67-expressing
cells examined in the SVZ (95.75 6 3.57 cells/section;
n 5 3 sections per brain, three brains; Fig. 1C) and
SGZ (8.74 6 1.93 cells/section; n 5 8 sections per
brain, three brains; Fig. 1D) expressed SIRT1. To con-
firm that SIRT1 was indeed expressed by neural precur-
sors, the expression of SIRT1 was also examined in iso-
lated neural precursors derived from both the SVZ and
the hippocampus. Neural precursors, when cultured in
vitro in the presence of mitogens, give rise to neuro-
spheres (Reynolds and Weiss, 1992). High levels of
SIRT1 expression were observed in the majority of cells
within proliferative neurospheres derived from both the
SVZ and the hippocampus (Fig. 1E). In contrast, low
SIRT1 immunoreactivity was observed in differentiated
neurospheres (Fig. 1E), suggesting that SIRT1 levels
may decrease during differentiation. To investigate this
further, we quantified the protein as well as the mRNA
transcript levels of Sirt1 in adult SVZ neurospheres in
the proliferative vs. the differentiative phases. A signifi-
cant 73.65% reduction in SIRT1 protein was observed
in differentiated neurospheres compared with proliferat-
ing neurospheres (Fig. 1F). To determine whether this
reduction in the levels of SIRT1 protein was due to a
decrease in transcription of Sirt1, we measured Sirt1
mRNA levels using quantitative reverse transcriptase
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Fig. 1. SIRT1 is expressed by proliferating precursors in the adult
neurogenic niches. Adult mouse coronal brain sections stained with
anti-SIRT1 antibody (green). Schematics of coronal sections through
the mouse brain illustrating the imaged area for the SVZ (A) and
hippocampus (B). A: SIRT1-expressing cells were found all along
the lateral wall of the SVZ (arrowheads). Control antibody (anti-IgG)
did not label any cells in the SVZ. B: In the hippocampus, SIRT1
staining was seen throughout the dentate gyrus, including the SGZ
(inset; white arrowheads). Proliferating cells labeled with Ki67 in the
SVZ (C) and SGZ (D) express SIRT1 (green). E: SIRT1 expression
(green) in proliferating (a) and differentiated (b) SVZ neurospheres.
F: Western blot analysis of the protein extracts from proliferating and
differentiated neurospheres using anti-SIRT1 and anti-b-actin anti-
bodies. SIRT1 protein was downregulated during differentiation.
GCL, granule cell layer; lv, lateral ventricle; SGZ, subgranular zone;
Str, striatum; SVZ, subventricular zone; h, hilus. Scale bars 5 100
lm in A,B; 40 lm in C,D. AQ1
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PCR (qRT-PCR) and found a 10.09- 6 0.78-fold
decrease in Sirt1 mRNA levels in differentiated neuro-
spheres compared with proliferating neurospheres (Stu-
dent’s t-test, P < 0.001).
SIRT1 Knock Down Does Not Affect SVZ and
Hippocampal Neural Precursor Numbers or Their
Proliferation but Enhances Their Neuronal
Differentiation
To address the role of SIRT1 in regulating neural
precursors, we designed a third-generation lentiviral vec-
tor expressing a reporter gene, GFP and SIRT1-specific
shRNA (LV-Sirt1shRNA; Fig.F2 2A). A lentiviral vector
expressing a scrambled shRNA sequence (LV-
ScramshRNA) was also generated to serve as a control
to eliminate nonspecific effects of shRNA production
within infected cells. The lentiviral backbone vector
(LV-GFP) served as an additional experimental control.
The infection efficacy of the resulting lentiviral particles
was found to be at least 90% as assessed by the number
of SVZ-derived GFP-expressing neurospheres (Fig. 2B).
When SVZ neurospheres infected with LV-Sirt1shRNA
neurospheres were stained for SIRT1, very little, if any,
SIRT1 expression was observed (Fig. 2C). Lentiviral-
mediated knock down of SIRT1 was also confirmed by
Western blot analysis of protein extracts from
Sirt1shRNA-infected and control ScramshRNA-infected
neurospheres. The SIRT1 protein in the neurospheres
was effectively reduced by 74.42% (Fig. 2D).
Having established successful knock down of
SIRT1 in neural precursors, we investigated its effect on
neural precursor numbers by performing the neurosphere
assay with SVZ-derived as well as hippocampal-derived
precursors. LV-Sirt1shRNA-mediated SIRT1 knock
down did not affect the number of neurospheres
obtained from either SVZ- or hippocampal-derived neu-
ral precursors (Student’s t-test, P > 0.05; Fig. 2E), sug-
gesting that SIRT1 has no regulatory effect on the num-
ber of activated neural precursors. Furthermore, Sirt1
knock down did not affect the diameter of the SVZ- or
hippocampal-derived neurospheres (data not shown),
suggesting that SIRT1 did not affect the proliferative
capacity of the precursors.
Next, we addressed whether SIRT1 signaling alters
the differentiation potential of neural precursors (Fig
F33A). In SVZ-derived differentiated neurospheres infected
with LV-Sirt1shRNA, there was a twofold increase in
the percentage of bIII-tubulin-expressing neurospheres
compared with the control LV-GFP- or LV-
ScramshRNA-infected neurospheres (one-way ANOVA,
P < 0.001; Fig. 3B). Upon quantification, a significant
increase in the average numbers of neurons per differen-
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Fig. 2. Lentivirus-mediated knock down of SIRT1 does not affect
precursor proliferation. Recombinant lentiviral particles were gener-
ated, SIRT1 shRNA (or scrambled shRNA) being expressed under the
U6 promoter and the reporter gene GFP driven under the CMV pro-
moter as shown in a schematic (A). B: Seven days after lentiviral infec-
tion of primary neural precursor cells, robust GFP expression was seen
in neurospheres. C: Differentiated neurospheres immunostained for
lentivirus-infected cells (GFP, green) and SIRT1 (red). SIRT1 immu-
noreactivity was absent in LV-Sirt1shRNA-expressing neurospheres.
D: Western blot analysis of primary neurospheres infected with LV-
ScramshRNA and/or LV-Sirt1shRNA showed effective knock down
of SIRT1 with SIRT1-specific shRNA. b-Actin served as a loading
control. E: Expression of LV-ScramshRNA or LV-Sirt1shRNA in
SVZ and hippocampal neural precursors had no effect on neurosphere
numbers. Data are represented as mean 6 SEM of three experiments. P
> 0.05. LV, lentiviral particles. Scale bars5 25 lm.
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tiated neurosphere was found in LV-Sirt1shRNA-
infected neurospheres compared with the controls (one-
way ANOVA, P < 0.001; Fig. 3C,D). Interestingly, fur-
ther analysis revealed a shift in distribution based on the
number of neurons contained per neurosphere, with
71.4% of LV-Sirt1shRNA neurospheres containing more
than 15 neurons compared with only 45.5% and 38.4%
of the LV-GFP and LV-ScramshRNA controls, respec-
tively (two-way ANOVA, P < 0.001; Fig. 3E).
To determine whether SIRT1 also regulated the
neuronal differentiation of hippocampal-derived neural
precursors, we repeated the in vitro SIRT1 knock down
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Fig. 3. SIRT1 knock down increases the neurogenic potential of
neural precursors. A: Diagram showing the experimental strategy. B:
The proportion of differentiated SVZ neurospheres expressing the
neuronal marker bIII-tubulin was significantly higher in neurospheres
infected with LV-Sirt1shRNA than in LV-GFP- and LV-
ScramshRNA-infected control neurospheres. C: Representative
images showing differentiated SVZ neurospheres expressing LV-
ScramshRNA or LV-Sirt1shRNA. Note the increased number of
bIII-tubulin-expressing neurons in LV-Sirt1shRNA-expressing neu-
rospheres. D: The average number of neurons present per neuro-
sphere also increased with SIRT1 knock down. E: Distribution pro-
file based on the percentage of neurospheres containing fewer than
15 (green), 16–30 (orange), and more than 30 (purple) neurons. F:
Percentage of total differentiated hippocampal neurospheres express-
ing bIII-tubulin. LV-Sirt1shRNA-infected hippocampal precursors
gave rise to a higher proportion of bIII-tubulin-expressing neuro-
spheres. Data are represented as mean 6 SEM of three experiments.
***P < 0.001. LV, lentiviral particles. Scale bar 5 25 lm.
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study. Similarly to our SVZ findings, SIRT1 knock
down in hippocampus-derived precursors also signifi-
cantly increased the number of differentiated neuro-
spheres containing bIII-tubulin-expressing neurons com-
pared with controls (one-way ANOVA, P < 0.001; Fig.
3F). However, because a hippocampal neurosphere con-
tains fewer neurons (one or two) than an SVZ-derived
neurosphere, we were unable to perform a detailed dis-
tribution analysis. Nevertheless, taken together, our data
suggest that SIRT1 signaling may be a common mecha-
nism that regulates the neurogenic potential of both
SVZ- and hippocampal-derived neural precursors.
SIRT1 Overexpression Does Not Affect the
Activity or Proliferation of SVZ- and
Hippocampal-Derived Neural Precursors but
Decreases Their Neurogenic Potential
Having demonstrated that SIRT1 knock down
enhances neuronal differentiation, we next questioned
whether SIRT1 overexpression was sufficient to inhibit
neuronal differentiation. To address this, we designed a
lentiviral construct overexpressing SIRT1 under the
ubiquitin promoter (LV-Sirt1-IRES-GFP). LV-IRES-
GFP was used as a control. Overexpression of SIRT1
was confirmed by Western blot analysis of protein
extracts from infected SVZ neurospheres and was found
to result in a 4.24-fold increase in SIRT1 protein levels
(Fig.F4 4A). We then examined the effect of SIRT1 over-
expression on the neurosphere-generating capacity of
SVZ and hippocampal neural precursors and found no
effect on the number of neurospheres derived from ei-
ther the SVZ or the hippocampus (Student’s t-test, P >
0.05; Fig. 4B), suggesting that overexpression of SIRT1
did not affect neural precursor numbers. Furthermore,
SIRT1 overexpression had no effect on neurosphere size
(data not shown), affirming that SIRT1 did not affect
the proliferative capacity of neural precursors. Next, we
examined the effect of increasing SIRT1 levels on the
neurogenic potential of precursors. This revealed an ap-
proximate 65% reduction in the number of differentiated
bIII-tubulin-expressing SVZ neurospheres derived from
LV-Sirt1-IRES-GFP-infected neural precursors (Stu-
dent’s t-test, P < 0.001; Fig. 4C). Hippocampal neuro-
spheres overexpressing SIRT1 showed a similar 60%
reduction in neuronal differentiation compared with
controls (Student’s t-test, P < 0.01; Fig. 4C). These data
suggest that overexpression of SIRT1 in neural precur-
sors is sufficient to block their neuronal differentiation.
Activation of SIRT1 Signaling Through
Resveratrol Decreases the Neuronal Differentiation
of Neural Precursors In Vitro
Having demonstrated that overexpression of
SIRT1 protein led to inhibition of neuronal differentia-
tion, we next questioned whether enhancing the deace-
tylase activity of SIRT1 would be sufficient to produce
a similar effect. For this we used Resveratrol, a small-
molecule activator of SIRT1 that acts by enhancing the
affinity of SIRT1 for its substrates, increasing its enzy-
matic activity by up to eightfold (Howitz et al., 2003;
Borra et al., 2005). We first evaluated the neurosphere-
generating capacity of neural precursors in the presence
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Fig. 4. SIRT1 overexpression inhibits neural precursors from differ-
entiating into neurons. A: Western blot analysis showing SIRT1
overexpression in SVZ neurosphere lysate infected with LV-SIRT1-
IRES-GFP compared with LV-IRES-GFP-infected neurosphere
lysate. b-Actin was the total protein loading control. B: Quantifica-
tion of the number of primary neurospheres obtained from SVZ and
hippocampal precursors infected with SIRT1-overexpressing lentiviral
particles. SIRT1 overexpression did not affect the number of SVZ or
hippocampal neural precursors. C: Quantification of the proportion
of differentiated SVZ and hippocampal neurospheres expressing the
neuronal marker bIII-tubulin. Neurospheres overexpressing SIRT1
had significantly reduced neurogenic potential compared with neuro-
spheres expressing the control GFP construct. Data are represented as
mean 6 SEM of three experiments. ns, P > 0.05, **P < 0.01, ***P
< 0.001.
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of increasing concentrations of Resveratrol. Resveratrol
has previously been shown to mediate Sirt1-dependent
functions in vitro at low concentrations of 0.1–5 lM
(Fremont, 2000; Prozorovski et al., 2008; Pervaiz and
Holme, 2009; Wallenborg et al., 2009). At these con-
centrations, Resveratrol did not have a significant effect
on either SVZ- or hippocampus-derived neurosphere
numbers (one-way ANOVA, P > 0.05; Fig. F55A,B).
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Fig. 5. Resveratrol reduces the number of neurons derived from
differentiated adult neurospheres. Effect of Resveratrol on the
neurosphere-generating capacity of SVZ (A) and hippocampal
(B) precursors. C: Representative images showing differentiated
SVZ (a,b) and hippocampal (c,d) neurospheres cultured in the
presence of 2 lM Resveratrol (a,c) or 0.2% DMSO (b,d). Note
the absence of bIII-tubulin-expressing neurons (red) in the
Resveratrol-treated neurospheres. D: Proportion of differentiated
SVZ neurospheres expressing bIII-tubulin. E: Neurosphere distri-
bution based on the number of bIII-tubulin-positive neurons per
neurosphere. F: Proportion of differentiated hippocampal neuro-
spheres expressing bIII-tubulin. Data are represented as mean 6
SEM of four experiments. *P < 0.05, ***P < 0.001. Scale
bars 5 40 lm.
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However, at concentrations of 10 lM and higher,
Resveratrol decreased neurosphere numbers in a concen-
tration-dependent manner (one-way ANOVA, P <
0.001; Fig. 5A,B).
Next, we assayed the effect of Resveratrol (0.1–4
lM) on neural precursor differentiation. When SVZ-
derived neural precursors were cultured and subsequently
differentiated in the presence of Resveratrol, a dose-
dependent reduction in the percentage of differentiated
SVZ neurospheres containing bIII-tubulin-expressing
neuronal cells was observed (one-way ANOVA, P <
0.001; Fig. 5C,D). Furthermore, we observed a signifi-
cant reduction in the number of bIII-tubulin-expressing
neurons in neurospheres grown and differentiated in the
presence of 2 lM Resveratrol, with 92.7% of Resvera-
trol-treated neurospheres containing fewer than 10 neu-
rons compared with 52.6% of control neurospheres
(two-way ANOVA P < 0.001; Fig. 5E). In the case of
hippocampal neural precursors, the proportion of differ-
entiated hippocampal neurospheres that produced bIII-
tubulin-expressing neurons was also markedly decreased
in the presence of 2 lM and 4 lM Resveratrol (one-
way ANOVA P < 0.001; Fig. 5C,F).
To ascertain whether this Resveratrol-induced in-
hibition was mediated through a Sirt1-dependent mech-
anism, we infected Resveratrol-treated neural precursors
with LV-GFP, LV-ScramshRNA, or LV-Sirt1shRNA
(Fig. F66A). SIRT1 knock down in SVZ-derived neural
precursors significantly rescued the inhibitory effects of
Resveratrol, producing only a 13% decrease in bIII-
tubulin-expressing neurospheres compared with an ap-
proximate 50% reduction in SVZ-derived precursors
infected with control LV-GFP or LV-ScramshRNA
(one-way ANOVA, P < 0.001; Fig. 6B). In addition,
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Fig. 6. SIRT1 knock down rescues Resveratrol-mediated neuronal
inhibition in vitro. A: Schematic diagram showing the experi-
mental strategy. B: SIRT1 knock down rescued the inhibition of
neuronal differentiation caused by Resveratrol treatment of SVZ-
derived precursors. C: Neurosphere distribution profiles based on
the percentage of SVZ neurospheres containing fewer than 15
(green), 16–30 (orange), and more than 30 (purple) neurons. D:
SIRT1 knock down in hippocampal neurospheres significantly
rescued the Resveratrol-induced reduction in neuronal differentia-
tion. Data are represented as mean 6 SEM of three experiments.
ns, P > 0.05, ***P < 0.001. LV, lentiviral particles; Rsv,
Resveratrol.
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quantification of the number of neurons produced per
neurosphere revealed a dramatic rescue of neuronal
numbers by SIRT1 knock down (two-way ANOVA, P
< 0.001; Fig. 6C). For instance, in LV-GFP- and LV-
ScramshRNA-infected neurospheres, Resveratrol treat-
ment resulted in no neurospheres containing more than
30 neurons compared with 36% and 26% of untreated
LV-GFP- and LV-ScramshRNA-infected neurospheres,
respectively (Fig. 6C). Sirt1shRNA rescued this Resver-
atrol-induced inhibition of neuronal differentiation, with
32% of Resveratrol-treated LV-Sirt1shRNA-infected
neurospheres containing more than 30 neurons (Fig.
6C). Furthermore, we also examined whether SIRT1
knock down was able to rescue the neurogenic potential
of Resveratrol-treated hippocampal neurospheres.
Indeed, SIRT1 knock down with LV-Sirt1shRNA sig-
nificantly rescued the Resveratrol-mediated inhibitory
effect, relative to Resveratrol-treated control LV-GFP-
and LV-ScramshRNA-infected neurospheres (one-way
ANOVA, P < 0.001; Fig. 6D). Together, these data
suggest that the Resveratrol-induced reduction in neuro-
nal differentiation of SVZ- and hippocampal-derived
neural precursors is dependent on SIRT1 signaling.
Genetic Ablation of SIRT1 Enhances Neurogenesis
So far, we have demonstrated that SIRT1 signaling
was both necessary and sufficient to regulate neuronal
differentiation of neural precursors in vitro. We next
sought to determine whether SIRT1 affected the neuro-
genic potential of neural precursors in vivo. To this end,
we generated mutant mice lacking the SIRT1 catalytic
domain in a brain-specific manner by crossing Sirt1
floxed transgenic mice (Li et al., 2007) with nestin-Cre
transgenic mice (Tronche et al., 1999). SIRT1 knockout
was confirmed by performing a Western blot analysis
with protein lysates of SVZ-derived neurospheres from
Sirt11/1, Sirt1KO/1, and Sirt1KO/KO adult mice (data
not shown). As expected, the Sirt11/1 neurosphere
lysate showed a protein band at 110 kDa. Sirt1KO/1 and
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Fig. 7. SIRT1 loss-of-function increases adult neurogenesis in the
SGZ. A: Representative schematic showing the BrdU injection para-
digm; 100 mg/kg BrdU was administered twice per day for 2 days,
and the mice were sacrificed after 7 days. The proportion of BrdU-
labeled cells that colabeled with DCX was quantified in the SGZ of
Sirt1KO and WT animals. B: Representative image showing colabel-
ing with DCX (green) and BrdU (red) in the SGZ. Inset shows a
magnified image of a cell colabeled for BrdU and DCX (arrow). C:
The proportion of BrdU-positive cells expressing DCX was signifi-
cantly increased in Sirt1KO animals. D: The average number of
BrdU-positive cells per square millimeter of SGZ was not affected by
SIRT1 ablation. E: A significant increase in the number of DCX-
expressing newborn neurons was observed per square millimeter of
SGZ in SIRT1 KO compared with WT control. Data are repre-
sented as mean 6 SEM of at least four animals per condition. ns, P
> 0.05, *P < 0.05, **P < 0.01. Scale bar 5 100 lm.
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Sirt1KO/KO mice expressed a SIRT1 mutant protein
because of the in-frame deletion of exon 4. In the pro-
tein lysate from Sirt1KO/KO mice, the mutant isoform of
the SIRT1 protein was detected, but no wild-type pro-
tein band could be seen at 110 kDa. In heterozygous
Sirt1KO/1 neurosphere lysates, two bands corresponding
to the wild-type and mutant SIRT1 isoforms were
detected. The homozygous Sirt1 knockout mice
(Sirt1KO/KO, hereafter referred to as ‘‘Sirt1KO’’) mice
had a lower body mass than littermate control mice
(hereafter referred to as ‘‘WT’’ for simplicity; WT 5
25.64 6 0.94 g vs. Sirt1KO 5 18.26 6 1.11 g; Stu-
dent’s t-test, P < 0.001; n 5 12 WT, 8 Sirt1KO mice).
In line with this decreased body weight, the brains of
the Sirt1KO mice were also lower in weight than the
WT brains (WT 5 41.58 6 1.51 mg vs. Sirt1KO 5
31.87 6 1.46 mg; Student’s t-test, P < 0.01; n 5 5
WT, 3 Sirt1KO brains).
To analyze the neurogenic potential of Sirt1KO
neural precursors in vivo, we performed a BrdU pulse
chase assay to follow the fate of newly dividing cells.
Sirt1KO and control WT mice were given four pulses
of BrdU, and the number of BrdU-positive cells express-
ing DCX was quantified 1 week after the last BrdU
pulse (Fig. F77A,B). When the number of colabeled cells
along the SGZ was quantified, the results revealed a sig-
nificant increase in the proportion of BrdU-positive cells
that colabeled with DCX in Sirt1KO mice compared
with their littermate WT controls (Student’s t-test, P <
0.01; Fig. 7C), suggesting that SIRT1 loss-of-function
led to a larger proportion of proliferating precursors dif-
ferentiating into neurons. We also quantified cell prolif-
eration in the SGZ by immunostaining for BrdU in the
mutant mice. This analysis revealed that BrdU-positive
cell numbers were comparable in Sirt1KO mice and
WT littermates (Student’s t-test, P > 0.05; Fig. 7D),
affirming that SIRT1 signaling does not affect precursor
proliferation. Having confirmed that SIRT1 loss-of-
function enhanced the neurogenic capacity of proliferat-
ing neural precursors in vivo, we asked whether
Sirt1KO mice had an increased number of newly formed
neurons. This analysis revealed a significant increase in
the total number of DCX-expressing cells in the SGZ of
Sirt1KO mice compared with their WT counterparts
(Student’s t-test, P < 0.05; Fig. 7E).
Next, to assess the effect of SIRT1 knockout on
the number of active neural precursors in the SVZ and
hippocampus of Sirt1KO, we used the in vitro neuro-
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Fig. 8. SIRT1 ablation enhances the neurogenic potential of adult
neural precursors. SVZ neural precursors obtained from SIRT1 defi-
cient (KO) mice have a higher neurogenic potential than those derived
from control (WT) mice. A: Proportion of primary SVZ neurospheres
containing bIII-tubulin expressing neurons. B: Average number of
neurons generated per neurosphere. C: Neurosphere distribution based
on number of the neurons within each neurosphere. D: Proportion of
hippocampal neurospheres containing bIII-tubulin-expressing neurons.
The neurogenic potential was enhanced in neural precursors derived
from Sirt1KO animals compared with WT mice. Data are mean 6
SEM of eight WT and five Sirt1KO animals. *P < 0.05, **P < 0.01,
***P < 0.001.
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sphere assay and quantified the total number of neuro-
spheres generated from these precursors. For SVZ-
derived neural precursors, we observed a significant
decrease in the total number of primary neurospheres
generated from the Sirt1KO animals (180.4 6 32.9)
compared with WT animals (326.4 6 23.43; Student’s
t-test, P < 0.001; n 5 8 WT, 5 Sirt1KO mice). How-
ever, because the brain weight of the Sirt1KO animals
was lower, there was a possibility that their neurogenic
regions were also smaller and thus contained fewer cells.
To investigate this, we quantified the number of neuro-
spheres generated per 105 cells isolated from SVZ and
found that the neurosphere-forming frequency in
Sirt1KO mice (1 in 1,333.89 6 281.19 cells) and their
WT littermates (1 in 840.43 6 98.55 cells) did not differ
significantly (Student’s t-test, P > 0.05). Similarly to the
SVZ, the total number of neurospheres derived from the
hippocampus of Sirt1KO mice (36.5 6 2.94) was also
J_ID: Z3P Customer A_ID: jnr-2012-Aug-4949.R1 Cadmus Art: JNR23199 Date: 11-JANUARY-13 Stage: I Page: 13
ID: rajarajan.s Date: 11/1/13 Time: 21:26 Path: N:/3b2/JNR#/Vol00000/120229/APPFile/JW-JNR#120229
Fig. 9. SIRT1 knock down increases neurogenic potential of precur-
sors in vivo. A: Schematic of a coronal brain section showing the
injection track terminating in the hilar region of the hippocampus.
B: Robust GFP (green) expression can be seen in the SGZ cells
infected with the lentiviral construct. C: Quantification of GFP-
expressing cells in the SGZ of LV-ScramshRNA- and LV-
Sirt1shRNA-infected mice. Both lentiviral constructs show compara-
ble infection efficiency. Representative images showing colocalization
of GFP (green) with DCX (D–F), GFAP (H–J), and Ki67 (L–N)
cells (in red) in the SGZ (arrowheads indicate colabeled cells).
G,K,O: Quantification of the proportion of DCX and GFP (G),
GFAP and GFP (K), and Ki67 and GFP (O) double-positive cells in
relation to GFP-expressing cells in the SGZ. SIRT1 knock down in
vivo increased the proportion of DCX-expressing newborn immature
neurons relative to all GFP-expressing cells in the SGZ. Data are
mean 6 SEM of eight mice per condition. ns, P > 0.05, **P <
0.01. LV, lentiviral particles; SGZ, subgranular zone. Scale bars 5
100 lm in B; 20 lm in F (applies to D–F); 20 lm in J (applies to
H–J); 20 lm in N (applies to L–N).
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dramatically reduced compared with that obtained from
control WT animals (15.25 6 2.14; Student’s t-test, P <
0.01; n 5 9 WT, 6 Sirt1KO mice). However, there was
no significant difference in the neurosphere-forming fre-
quency of hippocampal cells from Sirt1KO (1 in
15,108.19 6 3,754.06 cells) vs. WT mice (1 in 9,985.42
6 524.07 cells; Student’s t-test, P > 0.05).
Finally, to ascertain that the enhanced neurogenesis
observed in Sirt1KO mice in vivo was a direct conse-
quence of increased neurogenic potential of Sirt1KO
neural precursors, we tested the neuron-generating
capacity of SVZ and hippocampal neural precursors by
performing the in vitro differentiation assay with
Sirt1KO and WT neurospheres. A significantly higher
proportion of Sirt1KO SVZ neurospheres generated
bIII-tubulin-expressing neurons (Student’s t-test, P <
0.001; Fig.F8 8A). In addition, the average number of neu-
rons generated by each Sirt1KO neurosphere was also
significantly higher than that produced by the WT neu-
rospheres (Student’s t-test, P < 0.05; Fig. 8B). Further-
more, the distribution profile of the Sirt1KO neuro-
spheres revealed a significant bias toward a higher num-
ber of differentiated neurons per neurosphere compared
with the distribution profile of the WT neurospheres
(two-way ANOVA, P < 0.001; Fig. 8C). We also
investigated whether hippocampal neural precursors from
Sirt1KO mice exhibited an enhanced intrinsic neuro-
genic potential. In line with our previous data, we
observed a significant increase in the number of Sirt1KO
hippocampal neurospheres that gave rise to neuronal
progeny (Student’s t-test, P < 0.05; Fig. 8D).
Lentivirus-Mediated SIRT1 Knock Down Leads to
Increased Numbers of Newborn Neurons In Vivo
Although the Sirt1KO mice were invaluable for
studying the in vivo role of SIRT1 in adult hippocampal
precursors, the observed phenotype in these mice could
be due to either compensatory mechanisms arising dur-
ing development or secondary effects consequent to
germline deletion of Sirt1. To address specifically the
effects of in vivo SIRT1 knock down in the adult SGZ,
we used the lentiviral system to knock down SIRT1
expression in neural precursors residing within the SGZ
by administering LV-Sirt1shRNA stereotaxically into the
hilar region (Fig.F9 9A). Control mice were injected with
LV-ScramshRNA. The animals were sacrificed after a 2-
week period to permit transgene expression and to allow
the infected cells a window of opportunity in which to
differentiate. To assess the spread of lentiviral particles
within the brain, we analyzed brain sections of mice
infected with lentiviral vectors for distribution of GFP-
expressing cells. Two weeks after injection of the vec-
tors, GFP-expressing cells were mostly confined to the
SGZ, with some GFP-positive cells seen in the granule
cell layer of the dentate gyrus (Fig. 9B). No GFP-posi-
tive cells were detected in any other area of the hippo-
campus or in any other brain area. Evaluation of the
infection efficiency of LV-Sirt1shRNA and LV-
ScramshRNA, by quantification of the total number of
GFP-expressing cells per square millimeter of the SGZ,
revealed no significant difference in the number of GFP-
expressing cells (Student’s t-test, P > 0.05; Fig. 9C),
suggesting that both constructs had similar infection effi-
ciencies. Such selective manipulation of SIRT1 activity
in vivo combined with the fluorescence tagging of the
successfully silenced cells allowed us to test our in vitro
findings in vivo. To evaluate potential changes in neuro-
nal differentiation, we quantified the number of GFP-
expressing cells in the SGZ that colabeled with the early
neuronal marker DCX. This revealed a marked fourfold
increase in colabeled GFP-expressing and DCX-positive
cells in the SGZ of LV-Sirt1shRNA-infected mice com-
pared with control LV-ScramshRNA-infected mice
(Student’s t-test, P < 0.01; Fig. 9D–G). We next ques-
tioned whether SIRT1 knock down was specifically
enhancing the neurogenic potential of neural precursors
or whether it was also influencing their differentiation
into the other predominant neural precursor progeny,
glia. To assess this, we analyzed the proportion of GFP-
expressing cells that colabeled with the astroglial marker
GFAP and found no difference between the LV-
Sirt1shRNA- and control LV-ScramshRNA-injected
mice (Student’s t-test, P > 0.05; Fig. 9H–K).
To rule out any secondary effects caused by
increased precursor proliferation, we quantified the per-
centage of GFP-expressing cells that coexpressed Ki67, a
marker for proliferation. No difference was found
between mice injected with scrambled control and mice
injected with LV-Sirt1shRNA (Student’s t-test, P >
0.05; Fig. 9L–O), suggesting that SIRT1 knock down
did not affect proliferation. Moreover, to ascertain that
the observed increase in DCX-expressing cells was a
result of enhanced differentiation and not survival, we
performed a 2-week-long BrdU pulse chase experiment
with LV-Sirt1shRNA- and LV-ScramshRNA-injected
mice. This analysis revealed no difference in either the
total number of BrdU-positive cells per square milli-
meter of SGZ (LV-Sirt1shRNA 5 16.81 6 0.77, LV-
ScramshRNA 5 16.49 6 1.10; Student’s t-test, P >
0.05; n 5 8 sections per brain, four brains per condition)
or the proportion of GFP-expressing cells that coex-
pressed BrdU in the SGZ (LV-Sirt1shRNA 5 1.55 6
0.22, LV-ScramshRNA 5 1.73 6 0.31; Student’s t-test,
P > 0.05; n 5 8 sections per brain, four brains per con-
dition), suggesting that SIRT1 knock down had no
effect on the survival of newborn cells.
DISCUSSION
Here we provide the first evidence of a role for
SIRT1 in regulating adult neurogenesis. Our results
reveal that SIRT1 is strongly expressed by proliferating
neural precursors in both neurogenic regions of the adult
mouse brain, as demonstrated by colabeling with the
proliferation marker Ki67. Furthermore, we demonstrate
that SIRT1 has no effect on precursor proliferation but
inhibits their differentiation into a neuronal cell type, as
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evidenced by the finding that RNAi-mediated knock
down of SIRT1 enhanced neuronal differentiation of
both SVZ- and hippocampus-derived adult neural pre-
cursors in vitro. Similarly, neural precursors derived
from the SVZ and hippocampus of genetically ablated
Sirt1KO mice also showed no change in proliferation
but exhibited intrinsically enhanced neurogenic poten-
tial, as demonstrated by an increased number of bIII
tubulin-positive neuronal progeny in differentiated
Sirt1KO neurospheres in vitro. It may be that loss-of-
function of Sirt1 may result in a greater number of cy-
cling precursors differentiating into neurons at the
expense of other cell types, or alternatively it may influ-
ence the differentiation rate of precursor cells by acceler-
ating their exit from cell cycle toward neuronal fate.
Consistent with our in vitro findings, loss of
SIRT1 function in vivo, either through lentiviral-medi-
ated knock down or through genetic elimination,
resulted in enhanced neurogenic potential of hippocam-
pal precursors. In Sirt1KO animals, a higher percentage
of proliferating precursors was committed to a neuronal
fate, as shown by BrdU and DCX coexpression and the
finding that there was a significant increase in the total
number of newborn DCX-expressing cells within the
SGZ, demonstrating increased hippocampal neurogene-
sis. The DCX-positive lineage contains proliferating cells
as well as more mature neurons. Whether Sirt1 specifi-
cally regulates the DCX-positive proliferating neuroblast
population or newborn neuron pool is presently not
clear; however, the increase in DCX-positive neurons
observed following lentivirus-mediated SIRT1 downreg-
ulation in the adult SGZ provides further evidence that
SIRT1 has a direct inhibitory effect on adult neural pre-
cursor differentiation. Future studies utilizing a panel of
cell-type-specific marker expression will provide insights
into the stage-specific effects of Sirt1 in regulating quies-
cent vs. active precursor pools during adult neurogenesis.
In contrast to our findings, a study by Hisahara and
colleagues (2008) suggested that increased Sirt1 signaling
enhanced neuronal differentiation of the embryonic pre-
cursor cells by binding to nuclear receptor corepressor
(NCoR) and repressing the expression of Hes1. There
are several factors that may underlie these contrasting
observations, including age of animals, location from
which precursor cells were isolated, differentiation con-
ditions, and temporal window of examination. Impor-
tantly, the study by Hisahara and colleagues failed to
examine whether the effects of Sirt1 inhibitors in reduc-
ing neuronal differentiation were mediated via a Sirt1-
dependent mechanism. Overall, it is possible that Sirt1
has different regulatory functions in different cell types
and biological contexts and that Sirt1function is depend-
ent on the extrinsic factors presented by the cellular
microenvironment.
The inhibitory action of SIRT1 was further con-
firmed by overexpression of SIRT1, which had no effect
on proliferation but strongly inhibited neuronal differen-
tiation of SVZ as well as hippocampal neural precursors.
In line with the decrease in neuronal differentiation
observed with SIRT1 overexpression, increasing the en-
zymatic activity of SIRT1 with Resveratrol treatment
also led to decreased neuronal differentiation of both
SVZ and hippocampal neural precursors. Resveratrol has
previously been shown to mediate its biological effects
through both SIRT1-dependent and SIRT1-independ-
ent mechanisms (Baur, 2009; Pallas et al., 2009; Ogawa
et al., 2011; Kelly, 2011). Here we show that the inhibi-
tory effect of Resveratrol on neuronal differentiation is
mediated primarily by a SIRT1-dependent mechanism,
insofar as SIRT1 knock down restored the neurogenic
potential of Resveratrol-treated precursors.
Taken together, the findings described above dem-
onstrate that SIRT1 signaling affects the neurogenic
potential of both hippocampal and SVZ precursors. This
commonality of mechanism is striking given that adult
SVZ and SGZ neural precursors display distinct cellular
and functional properties, with SVZ neural precursors
exhibiting substantial proliferative activity and high neu-
rogenic potential in vitro (Reynolds and Weiss, 1996),
whereas SGZ precursors exhibit limited proliferative
capacity and reduced neurogenic capacity (Bull and Bart-
lett, 2005). Moreover, in contrast to the SVZ, the SGZ
contains a large population of latent precursors that can
be activated by signals that mimic synaptic activity in
vitro (Walker et al., 2008). However, despite the inher-
ent differences in the precursor populations residing in
these two niches, our results suggest that SIRT1 signal-
ing represents a conserved mechanism used by adult
neural precursors to regulate neuronal differentiation
negatively. Previous studies have implicated the role of
other class I and II HDACS in inhibiting neuronal dif-
ferentiation of adult neural precursors (Hsieh et al.,
2004; Siebzehnrubl et al., 2007; Kim et al., 2009),
whereas histone acetyl transferases such as Querkopf
have been shown to promote neuronal differentiation
(Merson et al., 2006). Given that, in Sirt1 knock down
animals, enough homeostatic and compensatory mecha-
nisms are still in place to allow for the development of a
grossly normal hippocampus, it is possible that several
HDACs along with other members of the Sirt1 family,
Sirt2–Sirt7, act together to regulate neuronal differentia-
tion of proliferating neural precursors and can therefore
partially compensate for Sirt1 loss-of-function.
Given the numerous studies that show a correlation
between hippocampal-dependent learning and adult hip-
pocampal neurogenesis (Gould et al., 1999; van Praag
et al., 1999; Lemaire et al., 2000; Matsumori et al.,
2006; Anderson et al., 2010), it is intriguing that two
recent studies, using the same nestin-Cre-mediated
SIRT1 knock down experimental strategy, indicated that
SIRT1 ablation in the brain results in deficits in hippo-
campal-dependent learning and memory (Gao et al.,
2010; Michan et al., 2010). Gao and colleagues (2010)
ascribed the behavioral defects to a corresponding
decrease in synaptic density and a reduction in long-
term potentiation. Our analysis of SIRT1 expression
shows that SIRT1 is robustly expressed in mature neu-
rons within the granule cell layer of the dentate gyrus,
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raising the possibility of an additional function for
SIRT1 in mature neurons in modulating synaptic plas-
ticity. Future studies utilizing a conditional genetic
approach will aid in determining the effects of selective
SIRT1 knock down in adult precursors on hippocam-
pal-dependent learning and memory tasks.
Our results suggest that SIRT1 levels within prolif-
erating precursors represent a crucial checkpoint that
regulates neuronal differentiation potential. In agreement
with this, we find that, although SIRT1 is strongly
expressed by proliferating neural precursors, its expres-
sion is significantly downregulated during the differentia-
tion of neurospheres in vitro. It has been shown that
SIRT1 levels decrease at the onset of neuronal differen-
tiation during embryonic development (Sakamoto et al.,
2004). Downregulation of SIRT1 protein with cell cycle
withdrawal has also previously been reported for mouse
embryonic fibroblasts (Sasaki et al., 2006). Furthermore,
our qRT-PCR analysis revealed a tenfold decrease in
Sirt1 mRNA levels in differentiated neurospheres,
strongly suggesting that downregulation of SIRT1 is pri-
marily regulated at the level of transcription.
An important question that arises from our findings
is, What regulates SIRT1? One of the strongest regula-
tors of SIRT1 activity is the coenzyme NAD1. Given
that the deacetylase reaction catalyzed by SIRT1 is
NAD1 dependent, SIRT1 activity is intimately linked
to the [NAD1]/[NADH] ratio within a cell, which rep-
resents its redox state (Landry et al., 2000). It has been
shown that differentiation of skeletal muscle cells is
accompanied by modifications of the [NAD1]/[NADH]
ratio, which exerts regulatory effects on SIRT1 (Fulco
et al., 2008). Recently, adult neural stem cells from the
SVZ have been shown to have a high redox potential
owing to high levels of reactive oxidative species (Le
Belle et al., 2010). It is conceivable that, in adult neural
precursors, SIRT1 responds to the redox state of a cell,
through its dependence on NAD1, to regulate processes
related to cell cycle and differentiation. In support of
this, Prozorovski and colleagues (2008) have shown that
redox state regulates neuronal differentiation in embry-
onic neural precursors through a SIRT1-dependent
mechanism. SIRT1 was shown to bind to Hes1 under
mild oxidative conditions in embryonic neural precur-
sors, resulting in transcriptional inhibition of Mash1, and
consequent inhibition of neuronal differentiation. SIRT1
has also previously been shown to interact with Hes1
and repress downstream target promoters (Takata and
Ishikawa, 2003). Hes1 is well known to inhibit neuronal
differentiation of embryonic stem cells during develop-
ment (Ohtsuka et al., 1999; Nakamura et al., 2000;
Kobayashi et al., 2009; Zhang et al., 2009), and its
expression has been demonstrated in SVZ- and SGZ-
derived adult neural precursors (Stump et al., 2002; Sui
et al., 2009; Wang et al., 2009). Given the expression
pattern of Hes1, its known role in regulating neuronal
differentiation, and the evidence for interaction between
Hes1 and SIRT1, it appears likely that SIRT1 associates
with Hes1 in adult neural precursors to form a corepres-
sor complex that inhibits neurogenic genes and prevents
neuronal differentiation. Together the data from this
study provide compelling evidence for the role of
SIRT1 in regulating adult neural precursor activity and
reveal SIRT1 as a negative regulator of the neurogenic
potential of these cells.
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